Agios Pharmaceuticals

88 Sidney Street
Cambridge, MA 02139-4169

Phone: 617-649-8600

Verification of employment

The Work Number
HR.operations@agios.com
Fax: 617-344-0070

For medical information queries, please contact us at the phone numbers or email addresses below.
Report an adverse event or product complaint anytime.

United States:

833-228-8474
medinfo@agios.com

Monday – Friday
8:00 am – 6:00 pm CT

Outside the United States:

France: +33 800 993264
Germany: +49 800 0010114
Italy: +39 800 934235
Spain: +34 900 752206

Monday – Friday
9:00 am – 5:00 pm Local standard time

All countries except those in the Gulf Cooperation Council (GCC):
ex-usmedinfo@agios.com

Gulf Cooperation Council (GCC) countries:
gccmedinfo@agios.com

Kingdom of Saudi Arabia:

Medical Inquiries or Product Complaints:
medinfo@nbpharma.com

Adverse Event reporting

Local Qualified Person Responsible for Pharmacovigilance: Asayel Moussa

Deputy Local Qualified Person Responsible for Pharmacovigilance: Saba Abdulrahman Bin huwaimel

Kingdom of Saudi Arabia:

المملكة العربية السعودية
للاستفسارات الطبية أو الشكاوى الخاصة بالمنتجات:
medinfo@nbpharma.com

الإبلاغ عن الآثار الجانبية:
المسؤول المحلي للتيقظ الدوائي: اصايل موسى
الهاتف المحمول (متاح على مدار الساعة وطوال أيام الأسبوع):
‎+966 55 779 9082

البريد الإلكتروني:
safety@balsam-cr.com

نائب المسؤول المحلي للتيقظ الدوائي: صبا عبد الرحمن بن هويميل
الهاتف المحمول (متاح على مدار الساعة وطوال أيام الأسبوع):
‎+966 55 426 2128

:البريد الالكتروني
safety@balsam-cr.com

For investor inquiries

Morgan Sanford
Vice President, Investor Relations
morgan.sanford@agios.com

For media inquiries

Eamonn Nolan
Senior Director, Corporate Communications
eamonn.nolan@agios.com

For clinical trial data requests

Complete our data sharing request form and send all requests to datasharing@agios.com

For partnering inquiries

partnering@agios.com

For information about TIBSOVO

Or other former Agios oncology programs,
please visit www.servier.us